Promega corporation:1107424 [14-053682]
Ended Awarded Last action
- Contract number
- HHSN26100010
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,152
Award facts
- Contract value 50% obligated
-
- $15,152.00 Current, with exercised options
- $30,225.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $79 | |
| Original award | $15,073 |
About this award
Promega Corporation received a $30,225 firm fixed price contract award from the National Cancer Institute on September 11, 2014, with an ultimate completion date of October 10, 2014. This award was issued as a call against a Blanket Purchase Agreement (BPA), with no small business set-aside designation applied. The contract was performed at Promega's facility in Madison, Wisconsin. Promega Corporation is a global life sciences company specializing in biological research, diagnostic, and forensic products, including DNA analysis systems, molecular diagnostic tools, and specialized laboratory reagents and consumables that support scientific research across multiple federal agencies.
This task order represents procurement activity under Promega's existing $10 million BPA with the National Institutes of Health's Office of Logistics and Acquisition Operations, which covers biological materials, chemicals, medical and scientific equipment, and maintenance services. The National Cancer Institute, as part of the NIH, regularly utilizes this vehicle for acquiring specialized laboratory supplies and equipment to support its cancer research mission. Promega's proven capability in providing advanced scientific instruments and reagents to federal research agencies is reflected in its history of contract awards from premier research and operational entities, including the NIH, Centers for Disease Control and Prevention, Food and Drug Administration, and Federal Bureau of Investigation.
Quick answers
Who was awarded contract HHSN26100010?
HHSN26100010 was awarded to Promega Corporation by National Cancer Institute (National Institutes of Health) on September 11, 2014.
How much is contract HHSN26100010 worth?
The government has obligated $15,152 on HHSN26100010. Its potential value, with all options, is $30,225.
Is contract HHSN26100010 an order under another contract?
Yes. HHSN26100010 is a BPA call under HHSN263199900051808B, a blanket purchase agreement.
Was contract HHSN26100010 competed?
The extent of competition for HHSN26100010 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award